WAC 246-320-171   Improving organizational performance.  The purpose of this section is to ensure that performance improvement activities of staff, medical staff, and outside contractors result in continuous improvement of patient health outcomes. In this section "near miss" means an event which had the potential to cause serious injury, death, or harm but did not happen due to chance, corrective action or timely intervention.

     Hospitals must:

     (1) Have a hospital-wide approach to process design and performance measurement, assessment, and improving patient care services according to RCW 70.41.200 and include, but not be limited to:

     (a) A written performance improvement plan that is periodically evaluated;

     (b) Performance improvement activities which are interdisciplinary and include at least one member of the governing authority;

     (c) Prioritize performance improvement activities;

     (d) Implement and monitor actions taken to improve performance;

     (e) Education programs dealing with performance improvement, patient safety, medication errors, injury prevention; and

     (f) Review serious or unanticipated patient outcomes in a timely manner;

     (2) Systematically collect, measure and assess data on processes and outcomes related to patient care and organization functions;

     (3) Collect, measure and assess data including, but not limited to:

     (a) Operative, other invasive, and noninvasive procedures that place patients at risk;

     (b) Infection rates, pathogen distributions and antimicrobial susceptibility profiles;

     (c) Death;

     (d) Medication use;

     (e) Medication management or administration related to wrong medication, wrong dose, wrong time, near misses and any other medication errors and incidents;

     (f) Injuries, falls; restraint use; negative health outcomes and incidents injurious to patients in the hospital;

     (g) Adverse events listed in WAC 246-320-146;

     (h) Discrepancies or patterns between preoperative and postoperative (including pathologic) diagnosis, including pathologic review of specimens removed during surgical or invasive procedures;

     (i) Adverse drug reactions (as defined by the hospital);

     (j) Confirmed transfusion reactions;

     (k) Patient grievances, needs, expectations, and satisfaction; and

     (l) Quality control and risk management activities.



[Statutory Authority: Chapter 70.41 RCW and RCW 43.70.040. 09-07-050, § 246-320-171, filed 3/11/09, effective 4/11/09.]